PAR — Paradigm Biopharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
- AU$143.29m
- AU$135.35m
- AU$8.12m
Australia Stock Exchange release from PARADIGM BIOPHAR : Notification regarding unquoted securities - PAR
Australia Stock Exchange release from PARADIGM BIOPHAR : Quarterly Update and Appendix 4C - quarterly
Australia Stock Exchange release from PARADIGM BIOPHAR : PRE_NR Ends: 15:26:03
Australia Stock Exchange release from PARADIGM BIOPHAR : Results of Meeting
Australia Stock Exchange release from PARADIGM BIOPHAR : Paradigm AGM Presentation
Australia Stock Exchange release from PARADIGM BIOPHAR : PARADIGM TREATS FIRST SUBJECTS IN PHASE 3 TRIAL OF ZILOSUL
Australia Stock Exchange release from PARADIGM BIOPHAR : PRE_NR Ends: 08:40:46
Australia Stock Exchange release from PARADIGM BIOPHAR : PAR REPORTS POSTIVE TOPLINE RESULTS IN HEART FAILURE MODEL
Australia Stock Exchange release from PARADIGM BIOPHAR : PRE_NR Ends: 12:40:58
Australia Stock Exchange release from PARADIGM BIOPHAR : Paradigm Presentation for Investor Webinar
Australia Stock Exchange release from PARADIGM BIOPHAR : Paradigm Investor Webinar
Australia Stock Exchange release from PARADIGM BIOPHAR : Application for quotation of securities - PAR
Australia Stock Exchange release from PARADIGM BIOPHAR : Preliminary Results from Phase 2 MPS I Study
Australia Stock Exchange release from PARADIGM BIOPHAR : PRE_NR Ends: 08:48:47
Australia Stock Exchange release from PARADIGM BIOPHAR : PRE_NR Ends: 08:57:25
Australia Stock Exchange release from PARADIGM BIOPHAR : Paradigm CEO Paul Rennie to transition to Non-Exec Chairman
Australia Stock Exchange release from PARADIGM BIOPHAR : Paradigm welcomes Dr Reiter from bene pharmaChem to the team
Australia Stock Exchange release from PARADIGM BIOPHAR : NOTICE OF RELEASE OF ESCROWED SECURITIES
Australia Stock Exchange release from PARADIGM BIOPHAR : Paradigm Presentation to Bell Potter Healthcare Conference